您的购物车当前为空
别名 MT-3995
Apararenone (MT-3995) 是一种新型的、非甾体类盐皮质激素受体 (mineralocorticoid receptor) 拮抗剂,正在开发用于糖尿病性肾病和非酒精性脂肪性肝炎的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
Apararenone (MT-3995) 是一种新型的、非甾体类盐皮质激素受体 (mineralocorticoid receptor) 拮抗剂,正在开发用于糖尿病性肾病和非酒精性脂肪性肝炎的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 186 | In Stock | |
| 5 mg | ¥ 413 | In Stock | |
| 10 mg | ¥ 588 | In Stock | |
| 25 mg | ¥ 917 | In Stock | |
| 50 mg | ¥ 1,320 | In Stock | |
| 100 mg | ¥ 1,930 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 331 | In Stock |
Apararenone 相关产品
| 产品描述 | Apararenone (MT-3995) is a receptor antagonist of mineralocorticoid receptor which can be used to treat non-alcoholic steatohepatitis and diabetic nephropathy. |
| 别名 | MT-3995 |
| 分子量 | 364.39 |
| 分子式 | C17H17FN2O4S |
| CAS No. | 945966-46-1 |
| Smiles | CC1(C)Oc2cc(NS(C)(=O)=O)ccc2N(C1=O)c1ccc(F)cc1 |
| 密度 | 1.389 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 125 mg/mL (343.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容